Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT06709235
Eligibility Criteria:
Inclusion Criteria:
* Patients with acute myeloid leukemia (AML)
* Age over 18 years
* Treatment with "intensive" chemotherapy (combination of aracytin and an anthracycline)
* Date of diagnosis of acute myeloid leukemia between 01/01/2015 and 31/12/2021
* Treatment received at Hospices Civils de Lyon (HCL)
Exclusion Criteria:
* Patients with acute promyelocytic leukemia (AML 3)
* Treatment with "non-intensive" chemotherapy (i.e. azacytidine)
* Death before first post-chemotherapy bone marrow assessment
* No computerized data available
* Follow-up at a center other than HCL
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06709235
Study Brief:
Protocol Section:
NCT06709235